[PERSON]
Guido Oelkers
Featured in 3 tracked stories · first seen
Situations
BioNTech restructuring, oncology shift, revenue cut
9 clusters · 34 sources · last updated
Latest: BioNTech slashes 2026 revenue outlook, reports loss and names Guido Oelkers as new CEO
In August 2026 BioNTech further cut its 2026 revenue outlook to €1.6‑1.9 billion, confirming a Q2 net loss of €820.8 million and a 60 % drop in revenue to €105.6 million. Shares fell to €79.15, about 6 % below the 200‑da
Also covered in
-
BioNTech appoints Guido Oelkers as CEO, succeeding co‑founder Ugur Sahin
[BUSINESS] · 10 sources ·